Mirza MR, Tandaric L, Henriksen JR, Maenpaa J, et al. NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancer. Gynecol Oncol 2024;188:103-110.
PMID: 38943691